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Background
Melanin is the pigment synthesized in the skin responsible for the
adaptive pigmentation in humans which protects from the danger-
ous and possible carcinogenic effects of UV rays present in the
sunlight (1). The main enzyme synthesizing melanin in the skin
melanocytes is tyrosinase whose natural substrate is tyrosine, but
can accept as substrates a large number of aromatic compounds
(S1) which may interfere with the production of melanin.
Premises
A larger number of aromatic and non-aromatic compounds inhi-
bit competitively or not competitively melanin activity reducing
or abolishing the melanin formation, reducing or preventing the
sun tanning of the skin (2). The vast majority of the organic UV
absorbers present in the sunscreens are aromatic compounds
(AC), and about one-third are phenols present at high concentra-
tion between 4 and 15% (www.tga.health.gov.au/docs/html/ar-
gom.htm). AC are frequently present also in other cosmetics, in
drugs and, in general, in products with which humans are in con-
tact daily. Most of these compounds were not properly tested for
their effects on tyrosinase, and particularly intriguing is their pos-
sible presence in sunscreen products. Salicylic acid (and presum-
ably salicylates), para-aminobenzoic acid (PABA) and benzoic
acid, largely present in sunscreens or other skin products, are in
fact established tyrosinase inhibitors (S2–S4).
Hypothesis
In the last years, many researchers have epidemiologically studied
whether sunscreen use influences the malignant melanoma (MM)
incidence upon sun exposure. Surprisingly, most of the researchers
(3–5; S5–S11) observed that sunscreen users have a higher inci-
dence of MM than non-users although at present a considerable
controversy exists. Huncharek and Kupelnick (6), in a meta-analy-
sis of these papers, have concluded that sunscreen use does not
increase nor diminish the MM incidence, a rather unexpected
conclusion given that sunscreens are supposed to filter UV light
which is claimed as the main cause of MM incidence.
In a previous paper (7), we have suggested that these hard to
explain epidemiological data may be explained by the presence in
sunscreens and in other cosmetic products of tyrosinase inhibitors
impairing the melanin synthesis which shields the skin from the
dangerous action of UV rays (Fig. 1). We have therefore decided
to test ten aromatic organic UV absorbers present in sunscreen
formulations and cosmetics. It may be seen in Fig. S1 that five of
the ten organic UV absorbers tested are almost insoluble in water,
and therefore, their activity on tyrosinase cannot be appreciated in
our experiments and their activity in vivo, in which the conditions
are very different, remains unknown. Three of the five remaining
compounds, Uvinul D50, Uvinul M40 and Uvinul MS40
(BASF, Ludwigshafen, Germany), are tyrosinase inhibitors. It is
noteworthy that Uvinul D50 is one of the most potent tyrosinase
inhibitors ever tested with a potency comparable to that of 4-n-
butylresorcinol (Fig. 2a,b). The other two are less potent and inhi-
bit tyrosinase at micromolar and millimolar concentrations
(Fig. 2c,d). Uvinul MS40 suppressed tyrosinase activity of
approximately 33% at 1 and 3 mM.
Our data demonstrate that other compounds, beside those
already reported, that are PABA, salicylic acid and benzoic acid,
may inhibit tyrosinase presumably hampering tanning. Two of the
organic UV absorbers, Uvinul M40 and MS40, are used preva-
lently in the sunscreen products at high concentration. The third
product, Uvinul D50, is not present in the sunscreens, at least in
USA and Europe as it was not authorized by the Food and Drug
Administration and the European authorities because it has potent
oestrogenic effects (S12), but incredibly it is present in an enor-
mous number of cosmetics, soaps, shampoos, etc. and therefore
may be used daily for whole life. Uvinul D50 is incredibly
potent, few micrograms inhibiting totally the tyrosinase.
Even if they are effective in filtering the UV rays, the likely
inhibition of the melanin synthesis in the skin is probably harmful
Figure 1. Cartoon showing the hypothesized double role of organic UV absorbers.
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increasing the genetic damage produced by UV rays and contrib-
uting to the continuous raising trend of MM. This can be coun-
terintuitive if considering a possible compensatory effect due to
the sunscreen, but it is realistic to hypothesize that the compensa-
tory effect is not complete. Due to the long human evolution
pathway (8), skin melanin should have, at least in theory, a much
higher efficacy (UV absorbing and protecting properties) than
anthropogenic sunscreens.
How to test the hypothesis
The relationship between melanoma and sunscreen use is difficult
to make. This hypothesis would be far less speculative if in vivo
data would be available. First of all, the real concentration of
tyrosinase inhibitor sunscreens at the level of the basal lamina
should be measured using microdialysis, and then, the effect of
these compounds on melanoma induced by carcinogenesis proto-
cols should be tested in mice.
Relevance and perspectives
Sunscreens are devised to protect us from the harmful effects of
UV rays: it seems incredible and paradoxical that these products
are not tested to evaluate their activity on tyrosinase, the enzyme
that provides us with the natural protection afforded by melanin.
It is our opinion that its use should be banned in any product
that may enter in contact with human skin. Alternatively,
advanced formulation strategies, which contemplate the organic
UV absorbers encapsulation or inclusion with no or minimal
release, should be strongly promoted. These novel formulation
approaches permit to reduce or completely eliminate the contact
between these molecules and the skin avoiding absorption. Encap-
sulated sunscreens remain efficient UV absorbers on the skin sur-
face (9,10).
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Figure S1. Names, molecular formula, molecular
weight, solubility and chemical structure of the 10 com-
pounds mentioned in the study.
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Abstract: Skin metabolism is becoming a major consideration in
the development of new cosmetic ingredients, skin being the first
organ exposed to them. In order to replace limited samples of
Excised human skin (EHS), in vitro engineered human skins
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Figure 2. (a) Inhibition of tyrosinase by different concentrations of Uvinul D50. (b)
Dose-inhibition relationship of tyrosinase activity estimated at 20 min. The line
represent the best fit of the data with Hill equation Abs norm = 1/(1 + ([Uvinul
D50]/IC50)^h), where IC50 and h represent the concentration the block half of
tyrosinase activity and the Hill coefficient, respectively. (c) Inhibition of tyrosinase by
UvinulM40. (d) Inhibition of tyrosinase by UvinulMS40 at different
concentrations. L-Tyrosine oxidation by tyrosinase was spectrophotometrically
determined as previously described with minor modifications [S13]. 150 ll of 5 mM
L-tyrosine in 67 mM sodium phosphate buffer (pH 6.8) was mixed with 50 ll of the
same buffer with or without the compound to test in a 96-well plate. The reaction
was started by further added 50 ll (150 U/ml) of mushroom tyrosinase (Sigma-
Aldrich, St. Louis, MO, USA). Dopachrome formation from the reaction mixture was
determined as the increase of absorbance at wavelength 492 nm per min (DA 492/
min) by using a Molecular Devices microplate reader every five minutes for 120 min.
All compounds used in the assay (Fig. S1) were dissolved in DMSO and diluted to the
finals concentrations of 50 and100 lM with exception UVINUL MS40 that was
dissolved in water. The final DMSO concentration in the assay was always <3%.
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